No record found


* Returns not adjusted for payouts
Company Profile
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
Mr. Farhan Muhammad Haroon | CEO |
Mr. Muhammad Zindah Moin Mohajir | Chairman |
Ms. Mashal Mohammad | Company Secretary |
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
Yousuf Adil, Chartered Accountants
December
Equity Profile
Announcements
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 27,507,212 | 24,163,150 | 19,846,106 | 16,316,745 |
Profit after Taxation | 325,411 | 2,134,334 | 1,262,009 | 1,257,519 |
EPS | 2.78 | 18.23 | 10.78 | 10.74 |
Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | |
---|---|---|---|---|
Sales | 6,593,614 | 7,087,103 | 7,127,151 | 6,079,605 |
Profit after Taxation | (345,213) | (279,313) | 556,599 | 363,894 |
EPS | (2.95) | (2.39) | 4.76 | 3.11 |

Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 17.40 | 27.38 | 26.85 | 30.56 |
Net Profit Margin (%) | 1.18 | 8.83 | 6.36 | 7.71 |
EPS Growth (%) | (84.75) | 69.11 | 0.37 | 16.99 |
PEG | (0.70) | 0.19 | 66.04 | 1.40 |